Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
Appendix B
Workshop Agenda
JULY 26, 2021
| 11:00 am | Welcome from the National Cancer Policy Forum and Overview of the Workshop |
| Richard L. Schilsky, University of Chicago | |
| Workshop Planning Committee Chair | |
| 11:10 am | Session 1: Cancer Care Delivery During the COVID-19 Pandemic and the Impact on Patients with Cancer |
| Moderators: | |
|
|
| Session Keynote: Impact of the COVID-19 Pandemic Across the Cancer Care Continuum | |
| Robert A. Winn, Virginia Commonwealth University Massey Cancer Center | |
| Patient Advocacy Perspective | |
| Shelley Fuld Nasso, National Coalition for Cancer Survivorship |
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
| Cancer Medicine in the Time of COVID-19: Organizational Collaborations | |
| Lawrence Shulman, University of Pennsylvania Abramson Cancer Center | |
| Community Oncology Perspective | |
| Randall A. Oyer, Association of Community Cancer Centers; Penn Medicine Lancaster General Health | |
| Integrated Care Perspective | |
| Steven Pergam, Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance | |
| COVID and Cancer Care: Lessons Learned in a Large, Academic Health Center | |
| Karen E. Knudsen, American Cancer Society | |
| Center for Medicare & Medicaid Innovation Perspective | |
| Lara Strawbridge, Center for Medicare & Medicaid Innovation | |
| Panel Discussion | |
| 12:35 pm | Transition Break |
| 12:50 pm | Session 2: Clinical Cancer Research During the COVID-19 Pandemic |
| Moderators: | |
|
|
| Session Keynote: Clinical Cancer Research During the COVID-19 Pandemic | |
| Mia Levy, Rush University Medical Center | |
| Challenges and Potential Benefits for Patients | |
| Jane Perlmutter, Patient Advocate | |
| Impact of COVID-19 on NCI-Supported Clinical Trials | |
| James Doroshow, National Cancer Institute |
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
| Impact of COVID-19 on Clinical Studies | |
| Fareed Melhem, Acorn AI Labs at Medidata | |
| COVID-19: Industry Challenges and Opportunities | |
| Dietmar Berger, Sanofi (Speaking on behalf of TransCelerate) | |
| Food and Drug Administration Perspective | |
| Sundeep Agrawal, Food and Drug Administration | |
| Panel Discussion | |
| 2:15 pm | Transition Break |
| 2:30 pm | Session 3: Roundtable Discussion: Telehealth in Cancer Care and Clinical Cancer Research: Opportunities, Constraints, and Unintended Consequences |
| Moderators: | |
|
|
| Session Keynote: Veterans Health Administration TeleOncology and Decentralized Clinical Trials | |
| Michael Kelley, Duke University; Durham VA Medical Center | |
| Panel Discussion | |
| Includes Michael Kelley and: | |
| Oncology Clinician Perspective | |
| Robin Zon, Michiana Hematology Oncology, PC | |
| Telehealth and Clinical Research | |
| David Spigel, Sarah Cannon Research Institute | |
| Scaling Virtual Care at an Academic Enterprise | |
| Inga T. Lennes, Massachusetts General Hospital | |
| NCI Research Initiatives to Advance Telehealth for Cancer Care | |
| Paul Jacobsen, Division of Cancer Control and Population Sciences, National Cancer Institute |
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
| Telehealth at the National Institutes of Health’s Clinical Center | |
| William L. Dahut, Center for Cancer Research, National Cancer Institute | |
| Food and Drug Administration Perspective | |
| Leonard Sacks, Food and Drug Administration | |
| Incorporating Telehealth into Medicare Fee-for-Service, Post-Pandemic | |
| Lee A. Fleisher, Centers for Medicare & Medicaid Services | |
| Policy and Payment Opportunities to Advance Virtual Cancer Care and Research | |
| Michael McNeely, Health Resources and Services Administration | |
| Q&A | |
| 4:00 pm | Wrap-Up Day 1 and Adjourn |
| Richard L. Schilsky, University of Chicago | |
| Workshop Planning Committee Chair |
JULY 27, 2021
| 11:00 am | Welcome and Overview of Day 2 |
| Richard L. Schilsky, University of Chicago | |
| Workshop Planning Committee Chair | |
| 11:10 am | Session 4: Learning Rapidly to Improve Cancer Care Delivery and Advance Health Equity Beyond the COVID-19 Pandemic |
| Moderators: | |
|
|
| Session Keynote: Delivering Cancer Care More Safely and Equitably in a Post-Pandemic Era | |
| Lori Pierce, American Society of Clinical Oncology President for 2020–2021; University of Michigan |
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
| Advancing Health Equity | |
| Marcella Nunez-Smith, Presidential COVID-19 Health Equity Task Force; Yale School of Medicine | |
| The Patient Experience Beyond the Clinical Walls: The Social Determinants of Health | |
| Shonta Chambers, Patient Advocate Foundation | |
| Impact of COVID-19 on Oncology Care: Payer Perspective on Cancer Care Improvement | |
| Bhuvana Sagar, Cigna | |
| Opportunities for Care Redesign for Vulnerable Communities | |
| Christopher Lathan, Dana-Farber Cancer Institute; Harvard Medical School | |
| Equity and Access to Radiation Therapy | |
| Karen Winkfield, Meharry-Vanderbilt Alliance | |
| U.S. Tribal Communities Perspective | |
| Loretta Christensen, Indian Health Service | |
| Panel Discussion | |
| 12:35 pm | Transition Break |
| 12:50 pm | Session 5: Learning Rapidly to Improve the Conduct of Cancer Clinical Research Beyond the COVID-19 Pandemic |
| Moderators: | |
|
|
| Session Keynote: Accelerating Research to Practice | |
| Douglas Lowy, National Cancer Institute | |
| Learning from the COVID-19 Pandemic: Expanding Opportunities for Robust Evidence Generation | |
| Paul Kluetz, Food and Drug Administration | |
| Impact of COVID-19 in Oncology: A Pharma Perspective | |
| Kald Abdallah, Bristol Myers Squibb |
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
| Insights Derived from Real-World Clinical Data | |
| Elizabeth Garrett-Mayer, American Society of Clinical Oncology | |
| Adaptive Platform Trials in COVID-19: Pros, Cons, and Potential Implications for Oncology | |
| Derek Angus, University of Pittsburgh Medical Center | |
| COVID-19 Vaccine Clinical Trials: Lessons Learned | |
| Randall Hyer, Moderna, Inc. | |
| Sustaining Progress of What We Learned from the COVID-19 Pandemic |
|
| Robert M. Califf, Verily Life Sciences and Google Health | |
| Panel Discussion | |
| 2:15 pm | Transition Break |
| 2:30 pm | Session 6: Panel Discussion: Collaboration and Coordination to Improve Cancer Care and Cancer Research in the Post-Pandemic Era |
| Moderator: Richard L. Schilsky, University of Chicago | |
| Panelists (Session Co-Moderators) | |
| Session 1: Nancy Davidson and Larry Shulman | |
| Session 2: Antoni Ribas and James Doroshow | |
| Session 3: Larissa Nekhlyudov and Karen Knudsen | |
| Session 4: Randall Oyer and Robert A. Winn | |
| Session 5: Samir Khleif and Donna Rivera | |
| Open Discussion | |
| 3:55 pm | Workshop Wrap-Up |
| 4:00 pm | Adjourn |
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
Suggested Citation:"Appendix B: Workshop Agenda." National Academies of Sciences, Engineering, and Medicine. 2022. Innovation in Cancer Care and Cancer Research in the Context of the COVID-19 Pandemic: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26470.
×
